| Patient | Mary McLeod Bethune |
|---|---|
| Date of birth | 1875-07-10 |
| Identifiers | MRN HR-ML043-SYN-TD; SSN (made up) 000-43-2195 |
| Document date | 1948-03-23 |
| Author | Samuel Oyelowo-Brandt, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Four months of wheeze, night cough and breathlessness on stairs in a 72-year-old never-smoking woman who has been told for many years that she has asthma but has never had lung function testing and has been treated with albuterol alone. Please confirm or refute asthma with spirometry before and after bronchodilator, DLCO and FeNO, help separate it from COPD and heart disease, and advise on treatment. [S]
Urgency: Within two weeks. [S]
Questions for the consultant:
Mrs. Bethune, 72, is seen at the request of Dr. Harrington-Mbeki for four months of worsening wheeze, night cough and breathlessness on exertion, on a background of asthma diagnosed clinically many years ago and never confirmed. She uses albuterol most days and has never had an inhaled corticosteroid. Triggers are colds, dust, perfume and humid air. She has never smoked. She has nasal blockage, postnasal drip and reduced smell, and evening heartburn. She has had no oral corticosteroid course, emergency visit or admission for asthma in the past year. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
4 later historical claims are omitted because they describe events after the index age. See the teaching note.
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Albuterol 90 mcg/actuation inhaler, two puffs as needed, from an urgent care visit four months ago (used alone, without an inhaled steroid) | Two puffs every 4 hours as needed; she uses it most days | Respiratory tract route | 1947-11-03 to 1948-03-23 | completed | S |
| Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 3): one inhalation twice daily and one inhalation as needed for symptoms, no more than 12 inhalations a day | One inhalation twice daily plus one as needed | Respiratory tract route | 1948-03-23 to 1948-06-15 | completed | S |
| Fluticasone propionate 50 mcg/actuation nasal spray, two sprays in each nostril once daily, aimed away from the septum | Two sprays each nostril daily | Nasal route | 1948-03-23 | active | S |
| Sodium chloride 0.65% nasal spray, two sprays in each nostril up to four times daily before the steroid spray | Two sprays each nostril up to four times daily | Nasal route | 1948-03-23 | active | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1948-03-23 | active | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1948-03-23 | active | S |
| Omeprazole 20 mg delayed-release capsule, one capsule daily 30 minutes before breakfast for eight weeks | One capsule daily before breakfast | Oral route | 1948-03-23 to 1948-05-18 | completed | S |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Wheeze, cough and breathlessness for four months: waking with cough and tight chest two or three nights a week, breathless on one flight of stairs, relieved by albuterol, worse with colds, dust and strong scents; known asthma for many years but never confirmed by lung function testing and never treated with an inhaled steroid. Asthma, COPD and heart failure to be distinguished: spirometry with bronchodilator response, FeNO and an echocardiogram booked | resolved | confirmed | R06.2 | S — Synthetic presenting problem anchored to her documented chronic asthma. Superseded by the diagnosis at the second visit. |
| Blocked nose, thick postnasal drip and a reduced sense of smell for years, worse in the last year; no nosebleeds; never seen by an ear, nose and throat specialist | active | confirmed | R09.81 | S — Synthetic upper-airway symptoms; superseded by the diagnosis of chronic rhinosinusitis after nasal endoscopy. |
| Gastro-esophageal reflux: heartburn and an acid taste two or three evenings a week, worse after late meals and lying down; no trouble swallowing, vomiting, black stools or weight loss | active | confirmed | K21.9 | S — Synthetic comorbidity of asthma; not a claim about her real health. |
| Obesity, class 1 (BMI 33.1); she wants to walk more and to keep up with her work, and agreed to talk about it | active | confirmed | E66.811 | S — Synthetic comorbidity recorded in her words and with her agreement; not a claim about her real weight. |
| Asthma, confirmed: variable airflow obstruction (FEV1 64 percent predicted, rising 270 mL or 21 percent after bronchodilator, with a normal post-bronchodilator FEV1/FVC of 0.72 and normal DLCO); type 2 inflammation (FeNO 46 ppb, blood eosinophils 0.42 x10^3/uL, total IgE 210, house dust mite sensitization); not COPD and not heart failure. Uncontrolled at diagnosis on albuterol alone | active | confirmed | J45.40 | S — Synthetic modern confirmation linked to her documented chronic asthma. |
| Hypertensive heart disease without heart failure: clinic blood pressure 152/88 and 146/86, home average 144/84; mild concentric left ventricular hypertrophy with grade 1 diastolic dysfunction and a normal ejection fraction (62 percent); BNP 48 pg/mL | active | confirmed | I11.9 | S — Synthetic finding of the modern work-up; not a claim about her real heart. |
| Hyperlipidemia: LDL cholesterol 144 mg/dL; 10-year ASCVD risk above 20 percent with hypertension | active | confirmed | E78.5 | S — Synthetic cardiovascular risk factor. |
Vital signs recorded on 1948-03-23; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Composed, speaking in full sentences; blood pressure 146/86, pulse 78; oxygen saturation 96 percent |
| Nose | Swollen, pale inferior turbinates; no polyps visible by anterior rhinoscopy |
| Respiratory | Scattered expiratory wheeze on forced expiration; no crackles |
| Cardiovascular | Regular rhythm; no gallop; jugular venous pressure not raised; no edema |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1948-03-23 | FEV1 --pre bronchodilation | 1.3 | L | Lower limit of normal, GLI Global race-neutral equations; predicted 2.03 L | Low | S |
| 1948-03-23 | FEV1 --post bronchodilation | 1.57 | L | Lower limit of normal, GLI Global race-neutral equations; predicted 2.03 L | Normal | S |
| 1948-03-23 | FEV1 measured/predicted | 64 | % | GLI Global race-neutral equations | Low | S |
| 1948-03-23 | FEV1/FVC | 0.64 | {ratio} | >=0.7 | Low | S |
| 1948-03-23 | FEV1/FVC --post bronchodilation | 0.72 | {ratio} | 0.70 or more after bronchodilator: no persistent airflow obstruction | Normal | S |
| 1948-03-23 | Diffusion capacity.carbon monoxide | 17.2 | mL/min/mm[Hg] | Lower limit of normal, GLI race-neutral; predicted 18.6 | Normal | S |
| 1948-03-23 | Fractional concentration of exhaled nitric oxide | 46 | [ppb] | Above 50 ppb high; 25 to 50 intermediate (ATS) | High | S |
| 1948-03-23 | Left ventricular Ejection fraction | 62 | % | 53-73% | Normal | S |
| 1948-03-23 | IgE [Units/volume] in Serum or Plasma | 210 | [IU]/mL | <=100 [IU]/mL | High | S |
| 1948-03-23 | Total score [ACT] | 14 | {score} | S |
Data reviewed: Dr. Harrington-Mbeki's intake note and results: chest X-ray with mild hyperinflation and normal heart size; ECG with LVH by voltage; blood eosinophils 0.42; BNP 48; Asthma Control Test 13. This morning, in our laboratory, with GLI Global race-neutral equations: FEV1 1.30 L (64 percent predicted) before and 1.57 L after albuterol 400 mcg (+270 mL, +21 percent); FEV1/FVC 0.64 before and 0.72 after; DLCO 17.2 (92 percent predicted); FeNO 46 ppb. Total IgE 210 IU/mL; specific IgE positive to house dust mite, negative to cat, dog, cockroach and mold. Transthoracic echocardiogram this morning: ejection fraction 62 percent, mild concentric LVH, grade 1 diastolic dysfunction, normal left atrium and right ventricle, estimated pulmonary artery systolic pressure 28 mmHg. [S]